Varian Medical Systems is the famous Corporate Investor, which was founded in 1948. The company was established in North America in United States. The main office of represented Corporate Investor is situated in the Palo Alto.
Considering the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations. The fund is generally included in less than 2 deals every year. The usual things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2018. Opposing the other organizations, this Varian Medical Systems works on 12 percentage points less the average amount of lead investments. The top activity for fund was in 2019.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Varian Medical Systems, startups are often financed by iSeed Ventures, BioAdvance, Versant Ventures. The meaningful sponsors for the fund in investment in the same round are TPG Biotech, Seroba Life Sciences, Johnson & Johnson Innovation. In the next rounds fund is usually obtained by Catalyst Health Ventures, TPG Biotech, Sparta.
Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. Among the most popular fund investment industries, there are Biotechnology, Biopharma. The fund has no exact preference in some founders of portfolio startups. When startup sums 5+ of the founder, the probability for it to get the investment is little. Among the most popular portfolio startups of the fund, we may highlight Fusion Pharmaceuticals, HistoSonics, Oncora Medical. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Related Funds
Fund Name | Location |
Abdiel Capital | New York, New York, United States |
Allston Venture Fund | Allston, Massachusetts, United States |
AsherMaximus | - |
Beijing Gehua CATV | Beijing, China, Haidian |
Capitol Ventures | - |
Curious Capital | Germany, Köln, Nordrhein-Westfalen |
Hauser Private Equity | Cincinnati, Ohio, United States |
HT Media Ltd | Delhi, India, New Delhi |
Josep Carreras Leukaemia Research Institute | Badalona, Catalonia, Spain |
Launch Alaska | Alaska, Anchorage, United States |
McCombs Partners | San Antonio, Texas, United States |
Pacific Sky Investments | Houston, Texas, United States |
Pagemill Capital | - |
RAD Ventures | California, United States, Venice |
Sheraa Sharjah | Sharjah, Sharjah, United Arab Emirates |
Sinopharm Holding GuoDa Drug Store Co. | China, Shanghai |
TOHO LEO | Japan, Osaka, Osaka Prefecture |
Turbostart | Bangalore, India, Karnataka |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
Lucata Corporation | $11M | 22 Apr 2021 | New York, New York, United States | ||
Bendit | 25 Mar 2021 | Sdot Dan Regional Council, Tel Aviv District, Israel | |||
HistoSonics | $40M | 08 Jun 2020 | Minnesota, United States | ||
Arterys | $28M | 29 May 2020 | San Francisco, California, United States | ||
HistoSonics | $54M | 08 Apr 2019 | Minnesota, United States | ||
Fusion Pharmaceuticals | $105M | 01 Apr 2019 | Hamilton, Ontario, Canada | ||
Arterys | $30M | 15 Nov 2017 | San Francisco, California, United States | ||
Fusion Pharmaceuticals | $21M | 25 Sep 2017 | Ontario | ||
SpaceOAR | $15M | 25 May 2011 | Massachusetts, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
Lucata Corporation | $11M | 22 Apr 2021 | New York, New York, United States | ||
Bendit | 25 Mar 2021 | Sdot Dan Regional Council, Tel Aviv District, Israel | |||
HistoSonics | $40M | 08 Jun 2020 | Minnesota, United States | ||
Arterys | $28M | 29 May 2020 | San Francisco, California, United States | ||
HistoSonics | $54M | 08 Apr 2019 | Minnesota, United States | ||
Fusion Pharmaceuticals | $105M | 01 Apr 2019 | Hamilton, Ontario, Canada | ||
Arterys | $30M | 15 Nov 2017 | San Francisco, California, United States | ||
Fusion Pharmaceuticals | $21M | 25 Sep 2017 | Ontario | ||
SpaceOAR | $15M | 25 May 2011 | Massachusetts, United States |